Colony Group LLC Organon & Co. Transaction History

Colony Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$31.66 - $38.9 $6,395 - $7,857	202 Added 2.17%	9,515 $321,000
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $13,854 - $17,908	455 Added 5.14%	9,313 $325,000
Q4 2021 Feb 15, 2022	SELL	$28.67 - $37.13 $457,802 - $592,891	-15,968 Reduced 64.32%	8,858 $270,000
Q3 2021 Nov 17, 2021	SELL	$28.63 - $35.64 $308,831 - $384,448	-10,787 Reduced 30.29%	24,826 $814,000
Q2 2021 Aug 18, 2021	BUY	$28.45 - $38.0 $1.01 Million - $1.35 Million	35,613 New	35,613 $1.08 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.02B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

Stay updated on Colony Group LLC with notifications on news.